Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India.

Dabak SV, Pilasant S, Mehndiratta A, Downey LE, Cluzeau F, Chalkidou K, Luz ACG, Youngkong S, Teerawattananon Y.

Health Res Policy Syst. 2018 Nov 29;16(1):115. doi: 10.1186/s12961-018-0378-x.

2.

Priority-setting, the Indian way.

Rao NV, Downey L, Jain N, Baru R, Cluzeau F.

J Glob Health. 2018 Dec;8(2):020311. doi: 10.7189/jogh.08.020311. Review. No abstract available.

3.

Validity and usability testing of a health systems guidance appraisal tool, the AGREE-HS.

Brouwers MC, Ako-Arrey D, Spithoff K, Vukmirovic M, Florez ID, Lavis JN, Cluzeau F, Permanand G, Bosch-Capblanch X, Chen Y; AGREE-HS Research Team.

Health Res Policy Syst. 2018 Jun 20;16(1):51. doi: 10.1186/s12961-018-0334-9.

4.

Identification of publicly available data sources to inform the conduct of Health Technology Assessment in India.

Downey L, Rao N, Guinness L, Asaria M, Prinja S, Sinha A, Kant R, Pandey A, Cluzeau F, Chalkidou K.

Version 2. F1000Res. 2018 Feb 28 [revised 2018 Jan 1];7:245. doi: 10.12688/f1000research.14041.2. eCollection 2018.

5.

Institutionalising health technology assessment: establishing the Medical Technology Assessment Board in India.

Downey LE, Mehndiratta A, Grover A, Gauba V, Sheikh K, Prinja S, Singh R, Cluzeau FA, Dabak S, Teerawattananon Y, Kumar S, Swaminathan S.

BMJ Glob Health. 2017 Jun 26;2(2):e000259. doi: 10.1136/bmjgh-2016-000259. eCollection 2017. Review.

6.

Adapting clinical guidelines in India-a pragmatic approach.

Mehndiratta A, Sharma S, Gupta NP, Sankar MJ, Cluzeau F.

BMJ. 2017 Nov 17;359:j5147. doi: 10.1136/bmj.j5147. No abstract available.

7.

Quality of Health Care in Ghana: Mapping of Interventions and the Way Forward.

Escribano-Ferrer B, Cluzeau F, Cutler D, Akufo C, Chalkidou K.

Ghana Med J. 2016 Dec;50(4):238-247.

8.

Clinical Pathways, Claims Data, And Measuring Quality.

Downey LE, Cluzeau FA, Chalkidou K.

Health Aff (Millwood). 2017 Feb 1;36(2):382-383. doi: 10.1377/hlthaff.2016.1517. No abstract available.

PMID:
28167734
9.

Combating antimicrobial resistance: quality standards for prescribing for respiratory infections in Vietnam.

Li R, van Doorn HR, Wertheim HFL, Khue LN, Ha NTB, Dat VQ, Hanh CT, Nga DTT, Trang NNM, Nadjm B, Cluzeau F, Kinh NV, Trung NV, Huong NTL, Chau NQ, Huong Q, Thao LT, Hong LTA, Oanh TTM, Islam J, Roberts CM, Chalkidou K.

Lancet Glob Health. 2016 Nov;4(11):e789. doi: 10.1016/S2214-109X(16)30267-4. No abstract available.

10.

Improving quality for maternal care - a case study from Kerala, India.

Vlad I, Paily VP, Sadanandan R, Cluzeau F, Beena M, Nair R, Newbatt E, Ghosh S, Sandeep K, Chalkidou K.

F1000Res. 2016 Feb 12;5:166. doi: 10.12688/f1000research.7893.1. eCollection 2016.

11.

Improving quality of primary care through financial incentives: the case of Thailand.

Gill P, Foskett-Tharby R, Cluzeau F, Tantivess S, Teerawattananon Y.

J R Soc Med. 2016 Aug;109(8):292-3. doi: 10.1177/0141076816655475. Epub 2016 Jun 20. No abstract available.

12.

Appraisal of maternity management and family planning guidelines using the agree II instrument in India.

Sonawane DB, Karvande SS, Cluzeau FA, Chavan SA, Mistry NF.

Indian J Public Health. 2015 Oct-Dec;59(4):264-71. doi: 10.4103/0019-557X.169651.

13.

Governance for health: special issue commentary.

Cluzeau F.

Public Health. 2015 Jul;129(7):864-5. doi: 10.1016/j.puhe.2015.06.005. Epub 2015 Jul 10. No abstract available.

PMID:
26169684
14.

Health technology assessment in universal health coverage.

Chalkidou K, Marten R, Cutler D, Culyer T, Smith R, Teerawattananon Y, Cluzeau F, Li R, Sullivan R, Huang Y, Fan V, Glassman A, Dezhi Y, Gyansa-Lutterodt M, McPherson S, Gadelha C, Sundararaman T, Squires N, Daulaire N, Sadanandan R, Shiro K, Lemgruber A.

Lancet. 2013 Dec 21;382(9910):e48-9. doi: 10.1016/S0140-6736(13)62559-3. No abstract available.

PMID:
24360390
15.

Improving health system quality in low- and middle-income countries that are expanding health coverage: a framework for insurance.

Mate KS, Sifrim ZK, Chalkidou K, Cluzeau F, Cutler D, Kimball M, Morente T, Smits H, Barker P.

Int J Qual Health Care. 2013 Oct;25(5):497-504. doi: 10.1093/intqhc/mzt053. Epub 2013 Aug 19.

PMID:
23959955
16.

Stakeholder involvement: how to do it right: article 9 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Cluzeau F, Wedzicha JA, Kelson M, Corn J, Kunz R, Walsh J, Schünemann HJ; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development.

Proc Am Thorac Soc. 2012 Dec;9(5):269-73. doi: 10.1513/pats.201208-062ST. Review.

PMID:
23256170
17.

Integrating values and consumer involvement in guidelines with the patient at the center: article 8 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Kelson M, Akl EA, Bastian H, Cluzeau F, Curtis JR, Guyatt G, Montori VM, Oliver S, Schünemann HJ; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development.

Proc Am Thorac Soc. 2012 Dec;9(5):262-8. doi: 10.1513/pats.201208-061ST. Review.

PMID:
23256169
18.

Guideline group composition and group processes: article 3 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Kunz R, Fretheim A, Cluzeau F, Wilt TJ, Qaseem A, Lelgemann M, Kelson M, Guyatt G, Schünemann HJ; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development.

Proc Am Thorac Soc. 2012 Dec;9(5):229-33. doi: 10.1513/pats.201208-056ST. Review.

PMID:
23256164
19.

The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium.

J Clin Epidemiol. 2012 May;65(5):526-34. doi: 10.1016/j.jclinepi.2011.10.008. Epub 2011 Dec 19.

PMID:
22189163
20.

AGREE II: advancing guideline development, reporting, and evaluation in health care.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium.

Prev Med. 2010 Nov;51(5):421-4. doi: 10.1016/j.ypmed.2010.08.005. Epub 2010 Aug 20. No abstract available.

PMID:
20728466
21.

AGREE II: advancing guideline development, reporting and evaluation in health care.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium.

J Clin Epidemiol. 2010 Dec;63(12):1308-11. doi: 10.1016/j.jclinepi.2010.07.001. Epub 2010 Jul 24. No abstract available.

PMID:
20656455
22.

AGREE II: advancing guideline development, reporting and evaluation in health care.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium.

CMAJ. 2010 Dec 14;182(18):E839-42. doi: 10.1503/cmaj.090449. Epub 2010 Jul 5. Review. No abstract available.

23.

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Hanna SE, Makarski J; AGREE Next Steps Consortium.

CMAJ. 2010 Jul 13;182(10):1045-52. doi: 10.1503/cmaj.091714. Epub 2010 May 31.

24.

Development of the AGREE II, part 2: assessment of validity of items and tools to support application.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Hanna SE, Makarski J; AGREE Next Steps Consortium.

CMAJ. 2010 Jul 13;182(10):E472-8. doi: 10.1503/cmaj.091716. Epub 2010 May 31.

25.

Conflicting recommendations. Let's not forget AGREE.

Cluzeau F; AGREE Research Trust.

BMJ. 2009 Feb 2;338:b407. doi: 10.1136/bmj.b407. No abstract available.

PMID:
19188229
26.

Guideline adaptation: an appealing alternative to de novo guideline development.

Palda VA, Graham ID, Davis D, Burgers J, Brouwers M, Cluzeau F; AGREE research trust.

Ann Intern Med. 2008 Apr 1;148(7):564; author reply 564-5. No abstract available.

PMID:
18378957
27.

Turning evidence into recommendations: protocol of a study guideline development groups.

Michie S, Berentson-Shaw J, Pilling S, Feder G, Dieppe P, Raine R, Cluzeau F, Alderson P, Ellis S.

Implement Sci. 2007 Sep 5;2:29.

28.

Predictors of high quality clinical practice guidelines: examples in oncology.

Fervers B, Burgers JS, Haugh MC, Brouwers M, Browman G, Cluzeau F, Philip T.

Int J Qual Health Care. 2005 Apr;17(2):123-32. Epub 2005 Jan 21.

PMID:
15665068
29.

International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument.

Burgers JS, Fervers B, Haugh M, Brouwers M, Browman G, Philip T, Cluzeau FA.

J Clin Oncol. 2004 May 15;22(10):2000-7.

PMID:
15143093
30.

Getting the guidance right: optimizing the quality of the UK national guidelines on sexually transmitted infections and closely related conditions.

Rooney G, Cluzeau FA, Daniels D, FitzGerald M, Ahmed-Jushuf I, Radcliffe K, Welch J.

Int J STD AIDS. 2004 May;15(5):297-8. No abstract available.

PMID:
15117495
31.

Clinical practice guidelines: towards better quality guidelines and increased international collaboration.

Grol R, Cluzeau FA, Burgers JS.

Br J Cancer. 2003 Aug;89 Suppl 1:S4-8. No abstract available.

32.

Characteristics of high-quality guidelines: evaluation of 86 clinical guidelines developed in ten European countries and Canada.

Burgers JS, Cluzeau FA, Hanna SE, Hunt C, Grol R.

Int J Technol Assess Health Care. 2003 Winter;19(1):148-57.

PMID:
12701947
33.

Clinical-practice guidelines in Europe: time for European co-operation for cancer guidelines.

Fervers B, Philip T, Haugh M, Cluzeau F, Browman G.

Lancet Oncol. 2003 Mar;4(3):139-40. No abstract available.

PMID:
12623358
34.

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).

Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW, Cluzeau F, Cooper C, Dieppe PA, Günther KP, Hauselmann HJ, Herrero-Beaumont G, Kaklamanis PM, Leeb B, Lequesne M, Lohmander S, Mazieres B, Mola EM, Pavelka K, Serni U, Swoboda B, Verbruggen AA, Weseloh G, Zimmermann-Gorska I.

Ann Rheum Dis. 2000 Dec;59(12):936-44.

35.
36.

Guidelines for evaluation.

Littlejohns P, Cluzeau F.

Fam Pract. 2000 Feb;17 Suppl 1:S3-6.

PMID:
10735260
37.
38.

Development and application of a generic methodology to assess the quality of clinical guidelines.

Cluzeau FA, Littlejohns P, Grimshaw JM, Feder G, Moran SE.

Int J Qual Health Care. 1999 Feb;11(1):21-8. Review.

PMID:
10411286
39.

The quantity and quality of clinical practice guidelines for the management of depression in primary care in the UK.

Littlejohns P, Cluzeau F, Bale R, Grimshaw J, Feder G, Moran S.

Br J Gen Pract. 1999 Mar;49(440):205-10.

40.

Appraising clinical guidelines: towards a "which" guide for purchasers.

Cluzeau F, Littlejohns P, Grimshaw JM.

Qual Health Care. 1994 Sep;3(3):121-2. No abstract available.

Supplemental Content

Loading ...
Support Center